Today announced that it intends to issue, subject to the approval of the TSX Venture Exchange, 11,145,999 common shares of PharmaCielo, at an effective price of $0.08 per Interest Share, in satisfaction of an aggregate of $891,681.85 in accrued semi annual interest payments due to holders of the Company's 11% secured debentures. PharmaCielo Ltd. shares V.PCLO are trading unchanged at $0.05.
Stocks in play: PharmaCielo Ltd.
Baystreet.ca - Baystreet - Contributor Content
This article could contain syndicated content. We have not reviewed, approved, or endorsed the content and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here